Big Tech Promises AI Cancer Cure in a Decade as Researchers Warn of Biological Limits

Sam Altman and other Big Tech figures have pledged that artificial intelligence will cure cancer within ten years, a claim researchers caution against because biological hurdles continue to slow progress. The debate, reported by Freitag based on Guardian material, centers on how far the technology can realistically advance medicine. The article opens with a personal account of a woman named June, called Nan by the narrator, who was dying of pancreatic cancer. Her failing liver gave her skin a ghostly apricot tone, and her bed seemed to swallow her as she looked out the window. June was described as pursued by the king of horrors and emperor of all diseases. Her chances of survival were characterized as "not good." Pancreatic cancer is the twelfth most common cancer worldwide and the sixth most common cause of cancer deaths. The piece questions whether AI-driven promises match the pace of biological reality, noting that researchers warn against false expectations. The full text appears in the current issue of Freitag.